Faculty

Splash Beverage Group Appoints Dr. John Paglia, a Professor of Finance at Pepperdine Graziadio Business School, to Its Board of Directors

Retrieved on: 
Friday, March 1, 2024

Dr. Paglia, age 56, is a tenured Professor of Finance at the Pepperdine Graziadio Business School where he teaches graduate level classes on the topics of corporate finance, business valuation, and mergers and acquisitions.

Key Points: 
  • Dr. Paglia, age 56, is a tenured Professor of Finance at the Pepperdine Graziadio Business School where he teaches graduate level classes on the topics of corporate finance, business valuation, and mergers and acquisitions.
  • in Finance from Gannon University, and is a Certified Public Accountant, Chartered Financial Analyst, and is NACD Directorship Certified™.
  • "We are honored to welcome John to our board of directors," said Robert Nistico, CEO and Chairman of Splash Beverage Group.
  • As a board member, I look forward to contributing to Splash’s vision and growth while working to increase shareholder value."

Ocugen Clinical Showcase Webcast Now Available

Retrieved on: 
Wednesday, February 28, 2024

MALVERN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Clinical Showcase webcast from the February 21, 2024 live event is now available in the Events & Presentations section of the Ocugen website.

Key Points: 
  • MALVERN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Clinical Showcase webcast from the February 21, 2024 live event is now available in the Events & Presentations section of the Ocugen website.
  • The showcase replay includes more detail on the Phase 3 study design for OCU400, as well as market potential for this first-in-class product candidate.
  • The panel discussion offers first-hand experience from an OCU400 Phase 1/2 clinical trial patient with the RHO mutation who has completed 12 months of therapy and lead investigator, Dr. Byron Lam, Professor of Ophthalmology, Mark J.
  • Please direct any questions related to the webcast to Tiffany Hamilton, Head of Communications, at [email protected] .

Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer

Retrieved on: 
Wednesday, February 28, 2024

NORWOOD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced the appointment of Dr. Dominic Smethurst, MA MRCP, as the Company’s Chief Medical Officer (CMO).

Key Points: 
  • NORWOOD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced the appointment of Dr. Dominic Smethurst, MA MRCP, as the Company’s Chief Medical Officer (CMO).
  • Additionally, Dr. Smethurst will help guide strategic development of CRB-913, the Company’s highly peripherally restricted CB1 inverse agonist for the treatment of obesity.
  • “We are pleased to welcome Dominic to the Corbus team and look forward to benefitting from his experience in developing novel oncology therapeutics including ones that specifically target Nectin-4", said Yuval Cohen, Ph.D., Chief Executive Officer of Corbus.
  • Previously, Dr. Smethurst worked as a consultant advising biopharma companies, providing guidance on clinical development strategies and licensing projects.

OCCC and POIETO host AI symposium for more than 300, new micro-credential in AI established

Retrieved on: 
Tuesday, February 27, 2024

OKLAHOMA CITY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Oklahoma City Community College (OCCC) and POIETO hosted more than 300 attendees at the inaugural Responsible AI in Education Symposium on Feb. 23.

Key Points: 
  • OKLAHOMA CITY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Oklahoma City Community College (OCCC) and POIETO hosted more than 300 attendees at the inaugural Responsible AI in Education Symposium on Feb. 23.
  • "Oklahoma City Community College is dedicated to advancing responsible AI practices in higher educational settings," said Dr. Mautra Staley Jones, president of OCCC.
  • "The Responsible AI in Education Symposium's engaging speakers, panels and workshops presented OCCC faculty and administrative staff with valuable insight on how to leverage AI to support academic and professional excellence."
  • Distinguished speakers from OCCC, University of Central Oklahoma, Oklahoma State University, Oklahoma City University, First Americans Museum, Oklahoma Contemporary, Robinson Park, the Oklahoma Office of Educational Quality and Accountability, ClearKinetic, BaB, Feminist AI, and POIETO also contributed their expertise.

AWIS Announces New Nevada Chapter

Retrieved on: 
Tuesday, February 27, 2024

WASHINGTON, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The Association for Women in Science (AWIS) is pleased to announce that another chapter has been established to serve the state of Nevada.

Key Points: 
  • WASHINGTON, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The Association for Women in Science (AWIS) is pleased to announce that another chapter has been established to serve the state of Nevada.
  • Brock says, “Our chapter is incredibly diverse which allows us to tap into a wealth of knowledge and experience.
  • If you are interested in learning more about the AWIS Nevada Chapter, please visit www.awisnevada.org , email [email protected] , or follow @AWISNevada on social media.
  • In addition to scholarships, AWIS provides career resources, and professional development, as well as networking, mentoring, and volunteer opportunities to build leadership skills.

iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)

Retrieved on: 
Tuesday, February 27, 2024

Dr. Hricak is a renowned radiologist and researcher with over 40 years of experience in the field.

Key Points: 
  • Dr. Hricak is a renowned radiologist and researcher with over 40 years of experience in the field.
  • Dr. Hricak is a member of the National Academy of Medicine and received the David Rall Medal, the NAM award for distinguished leadership.
  • The hallmark of her academic career has been developing, translating, and disseminating new diagnostic imaging techniques, primarily for genitourinary cancers.
  • “We are thrilled to welcome Dr. Hricak to the iCAD Board of Directors,” said Dana Brown, President, CEO, and Chairman of the Board.

Alberta Innovates Provides $12.4 million to Advance Health Innovations

Retrieved on: 
Monday, February 26, 2024

Dr. Abhilash Hareendranathan, from the Faculty of Medicine and Dentistry at the University of Alberta, is a recipient of an Accelerating Innovations into Care (AICE)-Concepts award from Alberta Innovates , and believes he has an answer to that question.

Key Points: 
  • Dr. Abhilash Hareendranathan, from the Faculty of Medicine and Dentistry at the University of Alberta, is a recipient of an Accelerating Innovations into Care (AICE)-Concepts award from Alberta Innovates , and believes he has an answer to that question.
  • This unique opportunity is part of the suite of AICE programs designed to advance health technologies toward market adoption with the aim of providing positive economic and health impacts for Alberta.
  • This year, 10 awards are being provided to researchers and innovators around Alberta for a total of $6.1 million.
  • We’re grateful that Alberta Innovates supports our researchers’ efforts to get their life-changing innovations from the lab to the bedside, to help improve outcomes for patients in Alberta and beyond.

Lincoln Educational Services Reports Results for Fourth Quarter and Full Year 2023

Retrieved on: 
Monday, February 26, 2024

PARSIPPANY, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the fourth quarter and full year ended December 31, 2023, as well as recent business developments.

Key Points: 
  • ET
    PARSIPPANY, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the fourth quarter and full year ended December 31, 2023, as well as recent business developments.
  • “During the fourth quarter, we achieved a 16% increase in student starts, all from existing campus operations, and grew revenue to more than $100 million.
  • The Lincoln 10.0 platform’s hybrid teaching model increases program efficiency and delivers accelerated revenue recognition in certain evening programs.
  • Educational services and facilities increased $4.5 million, or 12.4% to $41.0 million from $36.5 million in the prior year comparable period.

Pharmacy Benefit Management Institute® (PBMI) announces open registration for PBMI MAP: Managing Access and Patient Care

Retrieved on: 
Friday, February 23, 2024

CRANBURY, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- The Pharmacy Benefit Management Institute (PBMI), the nation’s leading provider of research and education on drug cost management, is pleased to announce open registration for the PBMI MAP: Managing Access and Patient Care virtual forum.

Key Points: 
  • CRANBURY, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- The Pharmacy Benefit Management Institute (PBMI), the nation’s leading provider of research and education on drug cost management, is pleased to announce open registration for the PBMI MAP: Managing Access and Patient Care virtual forum.
  • The forum will be held on March 8, 2024, where participants can join from the comfort of their homes.
  • The event is open to pharmacy benefit managers, self-insured employers, employer groups, commercial health plans, specialty pharmacy providers, third-party administrators, PBM service providers and pharmacy benefit consultants.
  • The event will include the following sessions:
    Current Landscape of Oncology Management, Access, and Patient Outcomes
    The event will feature the following esteemed faculty: Cheryl Allen B.S.

LiVDerm’s 22nd Annual South Beach Symposium Achieves Outstanding Success in Miami Beach

Retrieved on: 
Thursday, February 22, 2024

Hosted side by side, these two annual events brought together leading experts, practitioners, and industry professionals to exchange knowledge, share insights, and advance dermatologic care.

Key Points: 
  • Hosted side by side, these two annual events brought together leading experts, practitioners, and industry professionals to exchange knowledge, share insights, and advance dermatologic care.
  • Attendees had the opportunity to engage with renowned faculty members and explore the latest advances in both medical and cosmetic dermatology.
  • The enhanced exhibition hall served as a hub of innovation and networking, further enriching the symposium experience for all present.
  • "We are thrilled with the success of both symposia and the impact they've had on advancing dermatologic education and patient care.